Description

Paiva et al studied patients with hospital-acquired fungemia who were admitted to the intensive cre unit (ICU). These can help to identify patients who may benefit from more aggressive management. The authors are from the University of Porto in Portugal.


 

Patient selection: hospital-acquired fungemia and admitted to the ICU

(97% Candida species, 76% acquired in the ICU)

 

Outcome: 28 day mortality

 

On admission to the ICU the patient may be in septic shock and/or have renal failure. Fungal blood cultures should be taken on patients with hospital-acquired infection admitted to the ICU or acquired in the ICU.

 

Risk factors for mortality:

(1) hepatic failure

(2) need for mechanical ventilation

(3) medical admission (not surgical or other)

 

These tend to follow risk associated with multi-organ failure.

 

In this study a delay in adequate antifungal therapy was not an independent risk factor for mortality.

 


To read more or access our algorithms and calculators, please log in or register.